BPL

BPL, established in 1954, is a prominent manufacturer specializing in plasma-derived products. The company focuses on developing and producing critical therapeutic solutions, including albumin solutions, immunoglobulins, and coagulation factor solutions. Operating within the Chemicals, Petrochemicals, Glass & Gases and Manufacturing sectors, BPL has built a long-standing reputation for its contributions to healthcare. Its core business revolves around the complex processes required to extract and refine vital biological components for medical applications.

With a significant operational footprint, BPL employs between 1,000 and 5,000 individuals, indicating a substantial workforce dedicated to its specialized manufacturing processes. The company's single primary location in Elstree, Hertfordshire, United Kingdom, serves as its operational hub. Despite a singular listed location, its market reach is suggested by numerous geographical hashtags, implying a global presence or distribution network. The scale of its operations necessitates robust quality control and advanced biotechnological expertise.

BPL's revenue stands at $100.0M, reflecting its market position in the specialized biopharmaceutical industry. The company's product portfolio, including items like gammaplex, supports its role in providing essential medical treatments. For insights into the people driving these operations, one can Meet BPL's team. The company's longevity and focus on plasma-derived products position it as a key player in its niche, serving critical healthcare needs worldwide.